A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy

Journal of Clinical Gastroenterology

Volumn 26, Issue 4, 1998, Pages 287-290

  Tazuma, Susumu ^a   Kajiyama, Goro ^a   Mizuno, Toshiyuki ^a   Yamashita, Gunji ^a   Miura, Hiroyuki ^a   Kajihara, Tsuyoshi ^a   Hattori, Yoshihiro ^a   Miyake, Hiroaki ^a   Nishioka, Tomoji ^a   Hyogo, Hideyuki ^a   Sunami, Yasushi ^a   Yasumiba, Shigeyuki ^a   Ochi, Hidenori ^a   Matsumoto, Taiji ^b   Abe, Akio ^c   Adachi, Ken ^c   Omata, Fumio ^d   Ueno, Fumiaki ^d   Sugata, Fumio ^e   Ohguri, Shigeyoshi ^e   Shibata, Hisao ^f   Kokubu, Shigehiro ^f   more..

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Sanraku Hospital   (Japan)

^c SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^d TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

^e SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^f KITASATO UNIVERSITY   (Japan)

Author keywords

3 hydroxy,3 methylglutaryl coenzyme A reductase; Cholesterol gallstone; Cholesterol saturation index; Gallstone dissolution; Simvastatin

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLIC ACID; DEOXYCHOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LITHOCHOLIC ACID; PHOSPHOLIPID; SIMVASTATIN; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CHOLECYSTOGRAPHY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL STONE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GALLSTONE DISSOLUTION; GALLSTONE FORMATION; HUMAN; LIPID BLOOD LEVEL; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

BILE; CHOLELITHIASIS; CHOLESTEROL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID METABOLISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIMVASTATIN; URSODEOXYCHOLIC ACID;

EID: 0031744653     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199806000-00015     Document Type: Article

References (22)

1. Cooper J, Geizeroua M, Oliver M. Clofibrate and gallstones. Lancet 1975;1:1083.
2. The Coronary Drug Project Research Group. Gallbladder diseases as a side effect of drugs. N Engl J Med 1977;296:1185.
3. Grundy SM, Mok HYI, Berman M. Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 1981;22:24-36.
4. Duane WC, Hunninghake DB, Freeman ML, Pooler PA, Schlasner LA, Gebhard RL. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology 1988;8:1147-50.
5. Hoogerbrugge-vd Linden N, de Rooy FWM, Jansen H, Blankenstein M. Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolemia. Gut 1990;31:348-50.
6. Logan GM, Duane WC. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation. Gastroenterology 1990;98:1572-8.
7. Mazzella G, Parini P, Festi D, Bazzoli F, Aldini R, Roda A, Tonelli D, Cipolla A, Salzetta A, Roda E. Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia. Hepatology 1992;15:1072-8.
8. Horiuchi I, Ohya T, Tazuma S, Mizuno T, Takizawa I, Kajiyama G. Effects of pravastatin (CS-514) on biliary lipid metabolism in patients with hyperlipidemia. Metabolism 1991;40:226-30.
9. Tazuma S, Takizawa I, Kunita T, Mizuno T, Watanabe T, Teramen K, Horikawa K, Ochi H, Yamashita Y, Aihara N, Sasaki M, Hirano N, Miura H, Hatsushika S, Ohya T, Kajiyama G, Itoh K. Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia. Metabolism 1995;44:1410-2.
10. Saunders KD, Cates JA, Abedin MZ, Roslyn JJ. Lovastatin and gallstone dissolution: a preliminary study. Surgery 1993;113: 28-35.
11. Saunders KD, Cates JA, Abedin MZ, Rege SR, Festekdjian SF, Howard W, Roslyn JJ. Lovastatin inhibits gallstone formation in the cholesterol fed prairie dog. Ann Surg 1991;214:149-53.
12. Tazuma S, Hatsushika S, Aihara N, Sagawa H, Yamashita G, Sasaki M, Sasaki H, Mizuno S, Tao S, Kajiyama G. Inhibitory effects of pravastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in prairie dogs. Digestion 1992;51:179-84.
13. Smit JWA, vanErpecum KJ, Stolk MFJ, Geerdink RA, Cluysenaer OJJ, Erkelens DW, VanBerge-Henegouwen GP. Successful dissolution of cholesterol gallstone during treatment with pravastatin. Gastroenterology 1992;103:1068-70.
14. Smit JWA, vanErpecum KJ, Renooij W, Stolk MFJ, Edgar P, Doornewaard H, VanBerge-Henegouwen GP. The effects of the HMG-CoA reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. Hepatology 1995;21:1523-9.
15. Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNJ. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. Hepatology 1990;11:525-33.
16. Sackmann M, Niller H, Klueppelberg U, von Rittert C, Pauletzki J, Holl J, Berr F, Neubrand M, Sauerbruch T, Paumgartner G. Gallstone recurrence after shock-wave therapy. Gastroenterology 1994; 106:225-30.
17. Baily NA, Keller RA, Lasser EC. Computerized system for the measurement of gallstone volume, in vivo. Med Phys 1979;6:129-33.
18. Tazuma S, Hatsushika S, Yamashita G, Aihara N, Sasaki M, Horikawa K, Yamashita Y, Teramen K, Ochi H, Hirano N, Miura H, Ohya T, Hino H, Kajiyama G. Simultaneous microanalysis of biliary cholesterol, bile acids and fatty acids in lecithin using capillary column gas chromatography: an advantage to assess bile lithogenecity. J Chromatogr 1994;653:1-7.
19. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-55.
20. Igimi H, Carey MC. Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates. J Lipid Res 1981;22:254-70.
21. Salvioli G, Igimi H, Carey MC. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms. J Lipid Res 1983;24:701-20.
22. Turley SD, Herdon MW, Dietschy JM. Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster. J Lipid Res 1994;35:328-39.